- Home
- KELYA vs NMRA Comparison
KELYA vs NMRA Comparison
Compare KELYA & NMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KELYA | NMRA |
|---|---|---|
| Founded | 1946 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Professional Services | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 438.6M | 424.4M |
| IPO Year | N/A | 2023 |
Fundamental Metrics
Financial Performance| Metric | KELYA | NMRA |
|---|---|---|
| Price | $8.69 | $2.42 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 1 | 8 |
| Target Price | ★ $16.00 | $8.00 |
| AVG Volume (30 Days) | 571.0K | ★ 1.3M |
| Earning Date | 11-06-2025 | 11-06-2025 |
| Dividend Yield | ★ 3.46% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $4,392,800,000.00 | N/A |
| Revenue This Year | $4.55 | N/A |
| Revenue Next Year | $5.01 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 0.46 | N/A |
| 52 Week Low | $7.98 | $0.61 |
| 52 Week High | $15.71 | $11.57 |
Technical Indicators
Market Signals| Indicator | KELYA | NMRA |
|---|---|---|
| Relative Strength Index (RSI) | 32.63 | 50.37 |
| Support Level | $7.98 | $2.10 |
| Resistance Level | $9.20 | $2.78 |
| Average True Range (ATR) | 0.33 | 0.21 |
| MACD | 0.13 | -0.06 |
| Stochastic Oscillator | 59.43 | 35.00 |
Price Performance
Historical ComparisonAbout KELYA Kelly Services Inc.
Kelly Services Inc is a provider of workforce solutions and consulting, and staffing services. The company's operations are divided into four business segments, namely Professional & Industrial, Science, Education, Outsourcing & Consulting Group, and International. Other than OCG, each segment delivers talent through staffing services, permanent placement, or outcome-based services. OCG segment delivers talent solutions, including managed service providers, payroll process outsourcing, recruitment process outsourcing, and talent advisory services. International also delivers RPO talent solutions within its local markets. The majority of revenue is derived from Professional & Industrial.
About NMRA Neumora Therapeutics Inc.
Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.